Pablo Cironi is an accomplished professional in the life sciences and investment sectors, currently serving as Managing Director at Criteria Bio Ventures and a Board Member for multiple companies, including AbolerIS Pharma, MedLumics, S.L., AELIX Therapeutics, Minoryx Therapeutics, and several others. With extensive experience in financial leadership roles, Cironi has been the Director of Life Science Investment Funds and Principal at Caixa Capital Risc since September 2018. Cironi holds a Postdoctoral fellowship in Synthetic Biology - Protein Engineering from Harvard Medical School, a PhD in Organic Chemistry from Universitat de Barcelona, and an MSc in Chemistry from the University of Buenos Aires.
Links